COVID-19 Citizen Science Expansion Project - Trial NCT05548803
Access comprehensive clinical trial information for NCT05548803 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Enrolling by invitation. The study focuses on Covid19. Target enrollment is 150000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University of California, San Francisco
Timeline & Enrollment
N/A
Nov 24, 2020
Jun 01, 2023
Primary Outcome
Difficulty paying for the very basics,Time-to-testing if symptomatic
Summary
COVID-19 Citizen Science (CCS), launched in March 2020, supports collaborative research on
 symptoms, risk factors, surveillance, biomarkers and testing for COVID-19 using the Eureka
 Research Platform. CCS maintains IRB approval with UCSF's IRB (UCSF IRB# 17-21879).
 
 This CCS Expansion Project, which is funded jointly by the National Institutes of Health
 (NIH), the Patient-Centered Outcomes Research Institute (PCORI), and the Bill and Melinda
 Gates Foundation, will invite patients at health systems across the US to contribute their
 health records data and then join the established CCS study, allows for linked analysis of
 CCS data and health records data, and provides the scientific rationale and plan for the
 project.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05548803
Non-Device Trial